TMCnet News

PWRM, CBAI, PennyToBuck.com Watch List! for Friday Jan. 22, 2010, Cord Blood America, Inc. and Power3 Medical Products, Inc.
[January 21, 2010]

PWRM, CBAI, PennyToBuck.com Watch List! for Friday Jan. 22, 2010, Cord Blood America, Inc. and Power3 Medical Products, Inc.


PennyToBuck.com is pleased to announce its Hot Watch List! ***FREE Stock Alerts*** From PennyToBuck.com Click on the link Below: http://www.pennytobuck.com/signup __ PWRM, Power3 Medical Products, Inc., PWRM.OB PWRM is a leader in bio-medical research and the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets.



PWRM’s patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets, and its diagnostic tests are targeted toward markets with critical unmet needs in areas including neurodegenerative disease (NuroPro) and breast cancer (BC-SeraPro).

** PWRM will be a sponsor and have an exhibit booth at the 4th Annual Conference of the Alzheimer’s Drug Discovery Foundation on Drug Discovery for Neurodegeneration in Houston on February 1-2, 2010.


__ CBAI, Cord Blood America, Inc., CBAI.OB CBAI is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders.

Last October, CBAI opened its new Corporate headquarters and cryogenic research and storage laboratory in Las Vegas, NV.

The new Las Vegas lab reduces costs because lab services will no longer be outsourced (this subsequently will increase gross profits for CBAI) and increases CBAI’s revenue streams, with significant new opportunities to store other biological products and other lines of stem cells including stem cells from other companies.

With this, CBAI is looking to achieve its goal to become one of the largest cryogenic storage companies in the world.

Recently, CBAI signed a Letter of Intent to process and store cord blood specimens for BioCells, Inc. (the second largest stem cell storage company in Argentina with annual revenues of 1.5M (USD)), headquartered in Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico.

Furthermore, CBAI has contracted with BioE, St. Paul, Minnesota, to provide the newest “state of the art” cord blood processing systems for its Las Vegas operations. This includes BioE’s PrepaCyte® CB Processing System, which efficiently separates stem cells from cord blood for cryopreservation and eventual transplantation in humans.

** TOMORROW (Jan. 22) is the grand opening of CBAI’s 17,000 square foot stem cell laboratory and headquarters in Las Vegas, near the city’s international airport.

__ About PennyToBuck.com PennyToBuck.com is a stock watch website, that provides free daily alerts on stocks. PennyToBuck.com's alerts are daily e-mail on stocks that are hot in the market. These include stocks with huge volume, penny stocks, stocks with technical indicators and much more. PennyToBuck.com also tracks small cap stocks that are on the brink of moving upwards. PennyToBuck.com also features companies on its website with research report, analysis, and newsletters.

PennyToBuck.com is an independent electronic publication that provides information on selected publicly traded companies. PennyToBuck.com is not a registered investment advisor or broker-dealer. THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Please do your own Due Diligence before investing in any of the stocks mentioned above. The disclaimer is to be read and fully understood before using our sites, stock alerts, watch list or joining our email list. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and it has received an additional 1,000,000 shares 144 restricted stocks for 6 months of advertisement and diseminate news and $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB). Full disclaimer can be read at www.PennyToBuck.com We encourage investors to join the FREE e-mail alerts by visiting: http://www.pennytobuck.com/signup Forward Looking Statement This press release contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in this press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement.

***FREE STOCK ALERTS** Sign up to receive FREE stock alerts from PennyToBuck.com at http://www.pennytobuck.com/signup Contact PennyToBuck.com: [email protected] Office: (702) 448-1543 TOLL FREE: 1-877-854-6797

As a community-building service, TMCnet allows user submitted content which is not always proofed by TMCnet editors. If you feel this entry is of inferior quality or wish to report it for some reason, please forward the URL to "webedit [AT] tmcnet [DOT] com" with your comments.


[ Back To TMCnet.com's Homepage ]